Asymmetric bioreduction of (2-(4-nitro-phenyl)-N-(2-oxo-2-pyridin-3-yl-ethyl)-acetamide) to its corresponding (R) alcohol [(R)-N- (2-hydroxy-2-pyridin-3-yl-ethyl)-2-(4-nitro-phenyl)-acetamide] by using Candida sorbophila MY 1833 - stereospecific redu

Author： Chartrain M.   Roberge C.   Chung J.   McNamara J.   Zhao D.   Olewinski R.   Hunt G.   Salmon P.   Roush D.   Yamazaki S.   Wang T.   Grabowski E.   Buckland B.   Greasham R.  

Publisher： Elsevier

ISSN： 0141-0229

Source： Enzyme and Microbial Technology, Vol.25, Iss.6, 1999-09, pp. : 489-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis, antimicrobial and antimycobacterial evaluation of [2-(substituted phenyl)-imidazol-1-yl]-pyridin-3-yl-methanones

By Narasimhan Balasubramanian   Sharma Deepika   Kumar Pradeep   Yogeeswari Perumal   Sriram Dharmarajan  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 26, Iss. 5, 2011-10 ,pp. : 720-727

Informa Healthcare

Access to resources Recommend Favorite

Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor

By Wong H.   Chen J.Z.   Chou B.   Halladay J.S.   Kenny J.R.   La H.   Marsters J.C.   Plise E.   Rudewicz P.J.   Robarge K.   Shin Y.   Wong S.   Zhang C.   Khojasteh S.C.  

Xenobiotica, Vol. 39, Iss. 11, 2009-11 ,pp. : 850-861

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator

By Kearbey J. D.   Wu D.   Gao W.   Miller D. D.   Dalton J. T.  

Xenobiotica, Vol. 34, Iss. 3, 2004-03 ,pp. : 273-280

Informa Healthcare

Access to resources Recommend Favorite

Disposition and metabolism of (2S,3S,4R)-N''-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxy methyl-2H-benzopyran-4-yl)-N'-benzylguanidine, a novel neuroprotective agent for ischemia-reperfusion damage, in rats

By Kim N. S.   Yoo H. H.   Lee M. W.   Kim H. S.   Kim D. H.  

Xenobiotica, Vol. 37, Iss. 5, 2007-05 ,pp. : 534-548

Informa Healthcare

Access to resources Recommend Favorite

Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic––pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitor

By Liederer Bianca M.   Berezhkovskiy Leonid M.   Dean Brian J.   Dinkel Vikki   Peng Jing   Merchant Mark   Plise Emile G.   Wong Harvey   Liu Xingrong  

Xenobiotica, Vol. 41, Iss. 4, 2011-04 ,pp. : 327-339

Informa Healthcare

Access to resources Recommend Favorite